Nivolumab Before Surgery for Oral Cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests whether giving nivolumab (an immunotherapy drug) before surgery helps treat oral squamous cell carcinoma (a type of mouth cancer). Nivolumab helps your immune system fight cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have oral squamous cell carcinoma (mouth cancer) confirmed by biopsy that has not spread beyond the head and neck region
- Your cancer is advanced enough to require surgery but has not spread to distant parts of your body
- You are planning to have surgery as your main cancer treatment
- You have never received immunotherapy or chemotherapy before
- You are in good overall health (able to carry out daily activities with little or no assistance)
- You have not had an organ transplant and do not have active autoimmune diseases requiring ongoing immune-suppressing medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three drugs (adebrelimab, carboplatin, and albumin-bound paclitaxel) before surgery for people with advanced mouth cancer that can be removed. The goal is to see if this treatment can help shrink the tumor and improve outcomes.
This trial tests whether adding an immunotherapy drug (sintilimab) to standard chemotherapy before and after surgery can improve outcomes for people with advanced oral squamous cell carcinoma. The treatment is given first to shrink the tumor, then again after surgery to help prevent recurrence.
This study tests if giving immunotherapy before surgery helps treat oral cavity cancer. Researchers will look for markers in your biopsy that predict how well the treatment works.
This trial tests a new way to give an immunotherapy drug called nivolumab before surgery for head and neck cancer. The drug is injected directly into the tumor and is labeled with a fluorescent marker so researchers can see how it works in the removed tissue. This might help improve treatment for future patients.
This trial tests if two immunotherapy drugs, nivolumab and relatlimab, given before surgery can help shrink a type of skin cancer called cutaneous squamous cell carcinoma. It's for people whose cancer can be removed with surgery.
This trial tests a new immunotherapy drug (tirellizumab) combined with chemotherapy before surgery for early-stage oral cancer. It aims to see if this combination can help shrink the tumor and improve outcomes.
Hear when a new Oral Squamous Cell Carcinoma (OSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.